CATALOGO DEI PRODOTTI DELLA RICERCA

SENNA, GIANENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.542
EU - Europa 2.262
AS - Asia 1.102
AF - Africa 28
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 5.948
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.528
CN - Cina 755
IT - Italia 461
GB - Regno Unito 456
FR - Francia 272
IE - Irlanda 255
SE - Svezia 245
RU - Federazione Russa 239
SG - Singapore 220
DE - Germania 164
FI - Finlandia 90
VN - Vietnam 29
JP - Giappone 28
TG - Togo 24
UA - Ucraina 23
HK - Hong Kong 20
BE - Belgio 18
IN - India 15
TR - Turchia 11
CA - Canada 10
KR - Corea 10
NL - Olanda 8
AT - Austria 5
CH - Svizzera 5
ES - Italia 4
CL - Cile 3
MX - Messico 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AU - Australia 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EG - Egitto 2
EU - Europa 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
PE - Perù 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
HR - Croazia 1
IL - Israele 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SC - Seychelles 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.948
Salva come PNG Salva come JPEG
Città #
Chandler 626
Southend 422
Dublin 251
New York 213
Beijing 187
Jacksonville 157
Woodbridge 145
Singapore 142
Ashburn 135
Lawrence 109
Princeton 109
Wilmington 90
Verona 89
Houston 76
Ann Arbor 75
Sindelfingen 74
Jinan 60
Shenyang 53
Helsinki 43
Nanjing 38
Redmond 37
Hebei 36
Boardman 27
Bologna 27
Redwood City 27
Lomé 24
Ningbo 24
Changsha 23
Kent 23
Milan 22
Tokyo 22
Haikou 21
Nanchang 21
Norwalk 21
Seattle 21
Tianjin 21
Dong Ket 20
Guangzhou 20
Rome 20
Taizhou 19
Taiyuan 17
Hangzhou 16
Zhengzhou 16
Brussels 15
Dallas 15
Hong Kong 15
Jiaxing 10
Lanzhou 10
Seoul 10
Falls Church 9
Los Angeles 9
Bari 8
Lancaster 8
Padova 8
Lappeenranta 7
Palermo 7
Amsterdam 6
Chicago 6
Detroit 6
Enterprise 6
Fuzhou 6
Genoa 6
Fairfield 5
Naples 5
Toronto 5
Washington 5
Ancona 4
Arco 4
Boydton 4
Brescia 4
Clearwater 4
Delhi 4
Hyderabad 4
Monserrato 4
San Martino Buon Albergo 4
Trecate 4
Treviso 4
Bollate 3
Boston 3
Busto Garolfo 3
Chions 3
Dearborn 3
Dongguan 3
Istanbul 3
London 3
Madrid 3
Negrar 3
Newark 3
Riva 3
Riyadh 3
Santeramo in Colle 3
Texas City 3
Trento 3
Turin 3
Vienna 3
Abbiategrasso 2
Acquedolci 2
Altopascio 2
Barnet 2
Bishkek 2
Totale 3.914
Salva come PNG Salva come JPEG
Nome #
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management 190
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 103
Periostin: The bone and beyond 92
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience 90
La salute del respiro: epidemiologia, costi sanitari ed implicazioni sociali delle malattie respiratorie croniche in Europa e in Italia 89
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 86
Study on the Immunoreactivity of Triticum monococcum (Einkorn) Wheat in Patients with Wheat-Dependent Exercise-Induced Anaphylaxis for the Production of Hypoallergenic Foods 86
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 84
Impatto socio-sanitario e livello del controllo delle patologie respiratorie croniche ostruttive e della rinite in Italia 79
A double-blind placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects 74
Fatal asthma; is it still an epidemic? 74
Allergy and the bone: unexpected relationships 73
Analysis of the positivity rate in IgE positive patients to inhalant allergens in Verona Hospital Laboratory during 2002-2003 72
Scombroid syndrome: it seems to be fish allergy but... it isn't 72
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 69
How much specific is the association between hymenoptera venom allergy and mastocytosis? 69
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 69
Is hymenoptera venom allergy an occupational disease? 68
Wasp venom allergy screening with recombinant allergen testing. Diagnostic performance of rPol d 5 and rVes v 5 for differentiating sensitization to Vespula and Polistes subspecies 68
Potential benefit of omalizumab in respiratory diseases 67
Omalizumab management beyond clinical trials: the added value of a network model 66
Allergic rhinitis: pharmacotherapy in pregnancy and old age 66
What lies beyond Asthma Control Test: Suggestions for clinical practice 66
Thunderstorm Asthma: A Critical Appraisal Based on Clinical Practice 66
Adverse reaction to local anaesthetics: Is it always allergy? 64
The degree of serological sensitization to cat allergen in patients with or without cat at home 63
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma 63
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 63
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 62
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 62
Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma 60
Biologics for Eosinophilic Granulomatosis with Polyangiitis: one size does not fit all 59
Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain 58
Allergen Immunotherapy Adherence in the Real World: How Bad Is It and How Can It Be Improved? 58
Asthma management among different specialists: results from a national Italian survey 57
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 57
Biologic Therapy in a Patient with Asthma and Nasal Polyps 56
IgE to staphylococcal enterotoxins are undetectable in sera from patients with nasal polyposis 55
Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series 53
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic 53
Relevance of TH2 markers in the assessment and therapeutic management of severe allergic asthma: A real-life perspective 52
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 51
Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life 50
How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients 50
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 50
Evaluation of the IgE cross-reactions among vespid venoms. A possible approach for the choice of immunotherapy 49
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine? 49
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety 49
COPD prevalence in a north-eastern Italian general population 49
Component resolved diagnosis (CRD): how much is it presently used by Italian allergists? 48
BCG vaccination and COVID-19: Much ado about nothing? 48
Biologics and global burden of asthma: A worldwide portrait and a call for action 48
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 48
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 47
Biologic Therapy in a Patient with Asthma and Nasal Polyps 47
Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy 47
Uncontrolled Asthma: Unmet Needs in the Management of Patients 47
Evaluation of asthma control in the pharmacy: an Italian cross-sectional study 46
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 46
Asthma management among allergists in Italy: results from a survey 46
Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach? 45
Treatment with American Polistes venom was ineffective in an Italian patient allergic to European Polistes 44
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy 44
Emerging drugs for allergic conjunctivitis 44
ALLERGY AND CORONAVIRUS DISEASE (COVID-19) INTERNATIONAL SURVEY: REAL-LIFE DATA FROM THE ALLERGY COMMUNITY DURING THE PANDEMIC 44
Multidisciplinary management in type 2 inflammatory disease 44
Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia 44
Immunoblotting study of specific antibody patterns against latex and banana 43
Targeting eosinophils: severe asthma and beyond 43
Anaphylaxis and intimate behaviour 43
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis 43
The potential role of local pharmacies to assess asthma control: an Italian cross-sectional study 43
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 42
Orphan immunotherapies for allergic diseases 41
Biologics for the Treatments of Allergic Conditions 41
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 41
Effect of α1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy 41
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 40
The role of the pharmacy in the management of bronchial asthma: A literature-based evaluation 39
Serum periostin during omalizumab therapy in asthma: A tool for patient selection and treatment evaluation 39
Oral health in asthmatic patients: a review 39
Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply 39
Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges? 38
Sex in Respiratory and Skin Allergies 38
Use of complementary medicine among patients with allergic rhinitis: an Italian nationwide survey. 37
Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population 36
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 36
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control 36
Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine? 35
Safety and tolerability of sublingual immunotherapy in clinical trials and real life 34
Respiratory allergies in childhood: Recent advances and future challenges 33
Reconsidering anaphylaxis at the time of COVID-19 pandemic 33
One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response 33
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 32
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 32
Omalizumab for severe allergic asthma in clinical trials and real-life studies: what we know and what we should address 32
OCCUPATION study (OCCUPationl asthma: a naTIONal based study): a survey on occupational asthma awareness among Italian allergists 31
One year of mepolizumab. Efficacy and safety in real-life in Italy 30
Minimal clinically important difference for asthma endpoints: an expert consensus report 30
COVID-19 pandemic and environment: Not only air pollution 28
Totale 5.378
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.810
article - articoli 28.301
book - libri 263
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 246
Totale 57.620
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020375 0 0 1 15 39 48 25 14 14 92 78 49
2020/2021655 78 119 20 92 118 71 17 31 21 8 50 30
2021/2022712 85 172 19 45 16 14 15 48 50 13 51 184
2022/20231.844 139 158 190 266 179 421 31 108 222 15 76 39
2023/20241.338 52 92 119 168 114 282 89 63 20 58 192 89
2024/2025475 158 182 135 0 0 0 0 0 0 0 0 0
Totale 6.127